(Q39375100)

11 September 2017

Overexpression of forkhead box J2 can decrease the migration of breast cancer cells (English)

1 reference

11 September 2017

1 reference

1 reference

Yingying Wang

1

1 reference

11 September 2017

Shuyun Yang

2

1 reference

11 September 2017

Qichao Ni

3

1 reference

11 September 2017

Song He

4

1 reference

11 September 2017

Yunhong Zhao

5

1 reference

11 September 2017

Qin Yuan

6

1 reference

11 September 2017

Chunmiao Li

7

1 reference

11 September 2017

Hongwei Chen

8

1 reference

11 September 2017

Li Zhang

9

1 reference

11 September 2017

Lin Zou

10

1 reference

11 September 2017

Aiguo Shen

11

1 reference

11 September 2017

Chun Cheng

12

1 reference

11 September 2017

1 August 2012

1 reference

Journal of Cellular Biochemistry

11 September 2017

1 reference

11 September 2017

113

1 reference

11 September 2017

8

1 reference

11 September 2017

2729-2737

1 reference

FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

11 September 2017

1 reference

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

21 January 2018

1 reference

Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis

21 January 2018

1 reference

A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells

21 January 2018

1 reference

Forkhead-box transcription factors and their role in the immune system

21 January 2018

1 reference

The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection

21 January 2018

1 reference

Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1.

21 January 2018

1 reference

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells

21 January 2018

1 reference

Metastasis: recent discoveries and novel treatment strategies

21 January 2018

1 reference

DsRed as a potential FRET partner with CFP and GFP.

21 January 2018

1 reference

Fhx (Foxj2) expression is activated during spermatogenesis and very early in embryonic development.

21 January 2018

1 reference

Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

The forkhead box F1 transcription factor is expressed in brain and head mesenchyme during mouse embryonic development

21 January 2018

1 reference

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth

21 January 2018

1 reference

Significance of E-cadherin expression in triple-negative breast cancer

21 January 2018

1 reference

An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer

21 January 2018

1 reference

Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells

21 January 2018

1 reference

Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer

21 January 2018

1 reference

Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells

21 January 2018

1 reference

Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression

21 January 2018

1 reference

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

21 January 2018

1 reference

Biological effects of FoxJ2 over-expression

21 January 2018

1 reference

FOXA1 is an independent prognostic marker for ER-positive breast cancer.

21 January 2018

1 reference

Metastatic breast cancer: an updating

21 January 2018

1 reference

Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1.

21 January 2018

1 reference

FHX, a novel fork head factor with a dual DNA binding specificity

21 January 2018

1 reference

BRCA1 regulation of transcription

21 January 2018

1 reference

Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer

21 January 2018

1 reference

Lipocalin 2 promotes lung metastasis of murine breast cancer cells

21 January 2018

1 reference

Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.

21 January 2018

1 reference

Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer

21 January 2018

1 reference

FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases.

21 January 2018

1 reference

FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers

21 January 2018

1 reference

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

Forkhead box M1 transcriptional factor is required for smooth muscle cells during embryonic development of blood vessels and esophagus

21 January 2018

1 reference

FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness

21 January 2018

1 reference

The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo

21 January 2018

1 reference

Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4.

21 January 2018

1 reference

FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.

21 January 2018

1 reference

Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24146

1 reference

11 September 2017

1 reference